Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

SELL
$144.61 - $166.54 $147,646 - $170,037
-1,021 Reduced 2.0%
49,973 $7.96 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $229,732 - $275,510
-1,661 Reduced 3.15%
50,994 $8.24 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $7.07 Million - $8.11 Million
52,655 New
52,655 $7.07 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $4.81 Million - $5.35 Million
-45,677 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $423,419 - $466,134
-4,139 Reduced 8.31%
45,677 $4.94 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $180,297 - $243,420
-2,240 Reduced 4.3%
49,816 $5.34 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $88,401 - $103,754
-1,029 Reduced 1.94%
52,056 $4.56 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $98,609 - $131,953
-1,344 Reduced 2.47%
53,085 $5.21 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $317,533 - $481,420
-4,923 Reduced 8.29%
54,429 $4.15 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $4.28 Million - $5.36 Million
59,352 New
59,352 $5.26 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $3.38 Million - $4.06 Million
-53,674 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $224,365 - $286,791
-3,415 Reduced 5.98%
53,674 $3.9 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $1.7 Million - $2.01 Million
22,097 Added 63.15%
57,089 $4.6 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $190,654 - $235,128
-2,449 Reduced 6.54%
34,992 $3.23 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $3.33 Million - $3.7 Million
37,441 New
37,441 $3.54 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $9.99 Million - $13.4 Million
-108,567 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $1.56 Million - $1.71 Million
17,389 Added 19.07%
108,567 $10.5 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $79,209 - $101,175
-1,134 Reduced 1.23%
91,178 $8.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
92,312
92,312 $6.69 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $337B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Leuthold Group, LLC Portfolio

Follow Leuthold Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.